查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608213

无引线心臟心律调节器市场：按产品、最终用户划分 - 2025-2030 年全球预测

Leadless Cardiac Pacemaker Market by Product (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker), End-User (Academic & Research Institutes, Ambulatory Surgical Centers, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，无引线心臟心律调节器市值为2.7717亿美元，预计到2024年将达到2.9439亿美元，复合年增长率为7.83%，预计到2030年将达到4.7001亿美元。

无引线心臟心律调节器是心臟技术的重要进步，旨在为心搏过缓患者提供不需要电线或手术袋的起搏治疗。该设备使传统心律调节器小型化，降低感染风险并提高患者舒适度。其需要强调的是能够维持心率而不出现与经静脉导线系统相关的併发症。最终用户主要包括医院和循环系统诊所，适用于各种患者群体的心搏过缓治疗。无引线心臟心律调节器市场的成长是由心血管疾病盛行率上升、对微创手术的需求增加以及可穿戴医疗技术的技术进步等因素所推动的。机会存在于开拓的市场，在这些市场中，传统心律调节器仍然广泛使用，新兴国家的医疗设施正在升级。市场相关人员正在专注于与医疗保健提供者的伙伴关係，扩大研发力度，以进一步缩小设备尺寸，同时延长电池寿命，并提高成本效益以提高采用率。然而，市场面临着高昂的设备成本、严格的监管核准流程以及来自先进药物干预和新兴生物电子学等替代疗法的潜在竞争的挑战。其他限制包括目前无法提供双腔室起搏，这可能会限制其在某些患者群体中的使用。创新领域包括用于远端监控的物联网整合、更长的设备寿命以及针对更复杂的心臟疾病的扩展适应症。这个市场的本质是快节奏，高度依赖不断的技术创新，要求相关公司保持敏捷、具有前瞻性，并利用新兴技术来保持竞争力。

主要市场统计
基准年[2023] 27717万美元
预计年份 [2024] 2.9439亿美元
预测年份 [2030] 47001万美元
复合年增长率（%） 7.83%

市场动态：揭示快速发展的无引线心臟心律调节器市场的关键市场洞察

无引线心臟心律调节器市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心臟病盛行率上升
    • 心律调节器优惠报销措施
    • 扩大覆盖范围以减少术后併发症和感染疾病
  • 市场限制因素
    • 心律调节器的技术限制
  • 市场机会
    • 无引线心臟心律调节器的技术进步
    • 增加门诊手术中心的投资
  • 市场问题
    • 严格的政府措施和缺乏熟练的专家

波特五力：驾驭无引线心臟心律调节器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解无引线心臟心律调节器市场的外部影响

外部宏观环境因素在塑造无引线心臟心律调节器市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解无引线心臟心律调节器市场的竞争格局

对无引线心臟心律调节器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵：无引线心臟心律调节器市场供应商的绩效评估

FPNV定位矩阵是评估无引线心臟心律调节器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製无引线心臟心律调节器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，无引线心臟心律调节器市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心臟病发病率上升
      • 心律调节器优惠报销措施
      • 扩大覆盖范围以减少术后併发症和感染疾病
    • 抑制因素
      • 心律调节器的技术限制
    • 机会
      • 无引线心臟心律调节器的技术进步
      • 加大门诊手术中心建设投入
    • 任务
      • 严格的政府政策和缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章无引线心臟心律调节器市场：副产品

  • 介绍
  • Micra 经导管心律调节系统
  • Nano Stim 无导线心律调节器

第七章无引线心臟心律调节器市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 门诊手术中心
  • 医院

第八章美洲无引线心臟心律调节器市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太无引线心臟心律调节器市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲的无引线心臟心律调节器市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cairdac
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Vitatron Holding BV
Product Code: MRR-2E42D71A28F7

The Leadless Cardiac Pacemaker Market was valued at USD 277.17 million in 2023, expected to reach USD 294.39 million in 2024, and is projected to grow at a CAGR of 7.83%, to USD 470.01 million by 2030.

Leadless cardiac pacemakers represent a significant advancement in cardiac technology, designed to provide pacing therapy to patients with bradycardia without the need for wires or a surgical pocket. This device miniaturizes traditional pacemakers, reducing infection risks, and improving patient comfort. Their necessity is underscored by their ability to maintain heart rate without the complications associated with transvenous lead systems. End-users primarily include hospitals and cardiology clinics, with applications spanning bradycardia treatment across various patient demographics. The market growth for leadless cardiac pacemakers is driven by factors such as the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in wearable health tech. Opportunities lie in untapped markets where traditional pacemakers are still prevalent and developing nations are upgrading their medical facilities. Market players are advised to focus on partnerships with healthcare providers, expanding R&D activities to reduce device size further while enhancing battery life, and improving cost-effectiveness to enhance adoption rates. The market is, however, challenged by high device costs, stringent regulatory approval processes, and potential competition from alternative therapies like advanced pharmaceutical interventions or emerging bioelectronics. Limitations also include the current inability to provide dual-chamber pacing, which can limit their use in certain patient populations. Innovative areas ripe for exploration include integrating IoT for remote monitoring, enhancing device longevity, and expanding indications for use in more complex cardiac conditions, which will further cement their role in futuristic cardiovascular care. The nature of this market is fast-paced and heavily reliant on constant innovation, necessitating that companies involved are agile and forward-thinking, leveraging emerging technologies to maintain a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 277.17 million
Estimated Year [2024] USD 294.39 million
Forecast Year [2030] USD 470.01 million
CAGR (%) 7.83%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Leadless Cardiac Pacemaker Market

The Leadless Cardiac Pacemaker Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiac disorders
    • Favorable reimbursement policies for pacemakers
    • Increasing applicability to reduce postoperative complications and infections
  • Market Restraints
    • Technical limitations of pacemakers
  • Market Opportunities
    • Technological advancements in leadless cardiac pacemaker
    • Growing investments for advancement of ambulatory surgical centers
  • Market Challenges
    • Stringent governmental policies and scarcity of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Leadless Cardiac Pacemaker Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Leadless Cardiac Pacemaker Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Leadless Cardiac Pacemaker Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Leadless Cardiac Pacemaker Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Leadless Cardiac Pacemaker Market

A detailed market share analysis in the Leadless Cardiac Pacemaker Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Leadless Cardiac Pacemaker Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Leadless Cardiac Pacemaker Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Leadless Cardiac Pacemaker Market

A strategic analysis of the Leadless Cardiac Pacemaker Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Leadless Cardiac Pacemaker Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Boston Scientific Corporation, Cairdac, Lepu Medical Technology(Beijing)Co., Ltd., Medtronic PLC, and Vitatron Holding B.V..

Market Segmentation & Coverage

This research report categorizes the Leadless Cardiac Pacemaker Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Micra Transcatheter Pacing System and Nanostim Leadless Pacemaker.
  • Based on End-User, market is studied across Academic & Research Institutes, Ambulatory Surgical Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiac disorders
      • 5.1.1.2. Favorable reimbursement policies for pacemakers
      • 5.1.1.3. Increasing applicability to reduce postoperative complications and infections
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations of pacemakers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in leadless cardiac pacemaker
      • 5.1.3.2. Growing investments for advancement of ambulatory surgical centers
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent governmental policies and scarcity of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Leadless Cardiac Pacemaker Market, by Product

  • 6.1. Introduction
  • 6.2. Micra Transcatheter Pacing System
  • 6.3. Nanostim Leadless Pacemaker

7. Leadless Cardiac Pacemaker Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Hospitals

8. Americas Leadless Cardiac Pacemaker Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Leadless Cardiac Pacemaker Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Leadless Cardiac Pacemaker Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Boston Scientific Corporation
  • 3. Cairdac
  • 4. Lepu Medical Technology(Beijing)Co., Ltd.
  • 5. Medtronic PLC
  • 6. Vitatron Holding B.V.

LIST OF FIGURES

  • FIGURE 1. LEADLESS CARDIAC PACEMAKER MARKET RESEARCH PROCESS
  • FIGURE 2. LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LEADLESS CARDIAC PACEMAKER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LEADLESS CARDIAC PACEMAKER MARKET DYNAMICS
  • TABLE 7. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY MICRA TRANSCATHETER PACING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY NANOSTIM LEADLESS PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM LEADLESS CARDIAC PACEMAKER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. LEADLESS CARDIAC PACEMAKER MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. LEADLESS CARDIAC PACEMAKER MARKET, FPNV POSITIONING MATRIX, 2023